Literature DB >> 17924538

Nocturia: etiology, diagnosis, and treatment.

Rodney A Appell1, Peter K Sand.   

Abstract

Voiding at night, or nocturia, is a common reason for interrupted sleep in the adult population. The condition affects both men and women, with an incidence that increases dramatically with age. Nocturia has a negative impact on quality of life, affecting both morbidity and mortality. Effective diagnosis of the condition is dependent on a clear understanding of its underlying etiology. In general, the causes of nocturia fall into three categories: diurnal polyuria, nocturnal polyuria, and low bladder capacity. In some individuals, however, nocturnal polyuria and low bladder capacity may both contribute to the overall symptomatology of nocturia. Addressing any underlying conditions that contribute to nocturia is the first step in treating the condition. Lifestyle and behavioral changes may provide benefit in some individuals, but for many, the only option is pharmacotherapy. Antimuscarinic agents are first-line therapies for overactive bladder and are often used in the management of nocturia. Pharmacological and physicochemical differences between available antimuscarinic agents, however, translate into different safety and tolerability profiles, which may make some agents more suitable for use in certain populations, including the elderly. Careful selection of the most appropriate antimuscarinic medication is therefore central in optimizing treatment outcomes. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17924538     DOI: 10.1002/nau.20484

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  12 in total

1.  Lower Urinary Tract Symptoms and Risk of Nonspine Fractures among Older Community Dwelling U.S. Men.

Authors:  Lynn M Marshall; Jodi A Lapidus; Jack Wiedrick; Elizabeth Barrett-Connor; Douglas C Bauer; Eric S Orwoll; J Kellogg Parsons
Journal:  J Urol       Date:  2016-02-22       Impact factor: 7.450

Review 2.  Nocturia × disturbed sleep: a review.

Authors:  Daniele Furtado; Helena Hachul; Monica L Andersen; Rodrigo A Castro; Manoel B Girão; Sergio Tufik
Journal:  Int Urogynecol J       Date:  2011-08-17       Impact factor: 2.894

3.  How Does Adenotonsillectomy Affect the Olfactory Threshold in Children?

Authors:  Samireh Farshchi; Osman Mohammad Karim; Mohammad Amir Korani; Mohammadamin Joulani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-02-14

4.  Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study.

Authors:  Laura T Pizzi; Amy Talati; Eric Gemmen; Naomi V Dahl; Thomas J Bunz; Peter K Sand
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Safety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort study.

Authors:  Miho Song; Bum Sik Hong; Ji-Youn Chun; Ji-Yeon Han; Myung-Soo Choo
Journal:  Int Urol Nephrol       Date:  2014-03-05       Impact factor: 2.370

6.  Lower urinary tract symptoms increase the risk of falls in older men.

Authors:  J Kellogg Parsons; Jolee Mougey; Lori Lambert; Timothy J Wilt; Howard A Fink; Mark Garzotto; Elizabeth Barrett-Connor; Lynn M Marshall
Journal:  BJU Int       Date:  2009-01-19       Impact factor: 5.588

7.  A novel pathway underlying the inhibitory effects of melatonin on isolated rat urinary bladder contraction.

Authors:  June Hyun Han; In Ho Chang; Soon Chul Myung; Moo Yeol Lee; Won Yong Kim; Seo Yeon Lee; Shin Young Lee; Seung Wook Lee; Kyung Do Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-02-28       Impact factor: 2.016

8.  Efficacy of desmopressin in treatment of nocturia in elderly men.

Authors:  Bijan Rezakhaniha; Nahid Arianpour; Soheila Siroosbakhat
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

9.  Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia.

Authors:  Takashi Kawahara; Satoshi Morita; Hiroki Ito; Hideyuki Terao; Ryoko Sakata; Hitoshi Ishiguro; Katsuyuki Tanaka; Hiroshi Miyamoto; Junichi Matsuzaki; Yoshinobu Kubota; Hiroji Uemura
Journal:  BMC Urol       Date:  2013-06-12       Impact factor: 2.264

10.  Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study.

Authors:  Osamu Yokoyama; Akira Tsujimura; Hironobu Akino; Naoki Segawa; Satoshi Tamada; Naoki Oguchi; Yasuhide Kitagawa; Hidenori Tsuji; Akihiko Watanabe; Teruo Inamoto; Nobutaka Shimizu; Yasuyoshi Fujiuchi; Yoji Katsuoka; Haruhito Azuma; Tadashi Matsuda; Mikio Namiki; Hirotsugu Uemura; Akihiko Okuyama; Norio Nonomura; Hideki Fuse; Tatsuya Nakatani
Journal:  World J Urol       Date:  2014-09-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.